No products in the cart.
Anti-VEGF eye injections are a treatment for macular degeneration & diabetic retinopathy
Wet macular degeneration is one of the most common causes of blindness, anti-VEGF eye injection is a treatment.
Anti-VEGF eye injection is a modern treatment for wet AMD, which develops in about 1 in 10 cases of macular degeneration. Above is a video explaining how Anti-VEGF eye injection is used to treat wet macular degeneration. There are two types of macular degeneration: dry and wet macular degeneration. In the wet form of AMD, abnormal blood vessels grow in the back of the eye. Sometimes these vessels leak blood or fluid that causes blurred vision or distorted vision. Without treatment, vision loss may be quick and severe.
The patient should consult their retina specialist / ophthalmologist about signs and symptoms of Anti-VEGF side effects. Eye injections drugs are given by an eye surgeon. It is better and more effective than traditional laser eye surgery because it does not leave scarring in the macular central portion of vision.
Anti-VEGF side effects
Anti-VEGF eye injection for treatment of macular degeneration and diabetic retinopathy has few and rare side effects. The possibility of infection is extremely important to understand and the patient should consult their retina specialist / ophthalmologist about signs and symptoms of Anti-VEGF side effects.
Other uses for Anti-VEGF eye injection
More recently, Anti-VEGFs were approved for retinal vein occlusion and diabetic macular edema. These are two eye conditions that can cause profound vision loss. Adding Anti-VEGF eye injection to the vitreo-retina doctor’s arsenal is a big advancement in the retina eye care field.
Diabetic macular edema is one of the leading causes of vision loss in the world. It is caused by weakened and leaky capillaries in the retinal vascular system, due to diabetes.
Retinal vein occlusion can also cause macular edema. This condition, also known as cystoid macular edema, as responded well to Anti-VEGF eye injection. Anti-VEGF are now a mainstream treatment for these two eye conditions.